Kenya is set to revolutionize its HIV prevention strategy by introducing Lenacapavir, a twice-yearly injectable pre-exposure prophylaxis (PrEP) drug, by…
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.
